Back

Impact of female gender on prevalence rates, interventional strategies and prognosis in patients admitted with ST-elevation-myocardial infarction complicated by cardiogenic shock

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Prognosis post-acute coronary syndromes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andreas Fach

Hospital Links der Weser, Bremen (Germany)

7 More presentations in this session

Presentation thumbnail
Temporal trends in octo- and nonagenarians with ST-elevation-myocardial infarctions and impact of interventional results on prognosis
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Implication of myocardial perfusion abnormalities on clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusions
Mr J. Henningsen (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Pre-myocardial infarction symptom and short- and long-term cardiovascular mortality among acute myocardial infarction patients
Doctor S. Inaba (Shizuoka, JP)
Abstract Slides Video
Presentation thumbnail
Direct versus late maxLCBI4mm changes after paclitaxel-coated balloon treatment of lipid-rich plaques
Ms T. Dijkstra (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Fatal and non-fatal myocardial infarction in patients with possible angina referred for rapid outpatient assessment
Doctor M. Mcdermott (Edinburgh, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis post-acute coronary syndromes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Infarct-related cardiogenic shock and mechanical circulatory support
thumbnail
Congress Session
The best science in cardiac arrest and cardiogenic shock
thumbnail
Congress Session
Epidemiology of Takotsubo syndrome and acute coronary syndromes: focus on gender, cardiorenal syndrome and cancer

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources